Rationale And Objectives: To develop and externally validate interpretable CT radiomics-based machine learning (ML) models for preoperative Ki-67 expression prediction in clear cell renal cell carcinoma (ccRCC).

Methods: 506 patients were retrospectively enrolled from three independent institutes and divided into the training (n=357) and external test (n=149) sets. Ki67 expression was determined by immunohistochemistry (IHC) and categorized into low (<15%) and high (≥15%) expression groups. Radiomics features were extracted from segmented tumor regions in the corticomedullary phase (CMP) CT images using the "PyRadiomics" package. The least absolute shrinkage and selection operator (LASSO) regression was applied to select the most relevant radiomics features for Ki-67 expression, which were then used to train five ML models. Models' performances were evaluated via the receiving operator curve analysis and compared using Delong test. Calibration and decision curve analyses assessed the models' clinical utility. Kaplan-Meier analysis and Log-rank tests were conducted to determine the prognostic value of radiomics-predicted Ki-67 expression status. The optimal model was interpreted using SHapley Additive exPlanations (SHAP).

Results: Eight radiomics feature were selected to build models using Random forest (RF), eXtreme Gradient Boosting (XGBoost), Logistic regression (LR), Support vector machine (SVM), and K-nearest neighbor (KNN). The RF model exhibited the best performance, achieving the highest area under the curve (AUC) in both the training (0.910, 95% confidence interval [CI]: 0.881-0.936) and external test (0.885, 95% CI: 0.826-0.934) sets, as confirmed by Delong test (all P values<0.05). Calibration and decision curves further demonstrated the superior clinical utility of the RF model. Both IHC-based and RF-predicted high Ki-67 expression groups were significantly associated with a higher risk of tumor recurrence in the training and external test sets (all P values<0.05). The prediction process of the RF model was uncovered in the globe and individualized terms using the SHAP.

Conclusion: The interpretable CT radiomics-based RF classifier exhibited robust predictive performance in assessing Ki-67 expression levels preoperatively, offering valuable prognostic insights and aiding clinical decision-making in ccRCC patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2024.11.072DOI Listing

Publication Analysis

Top Keywords

interpretable radiomics-based
8
radiomics-based machine
8
machine learning
8
ki-67 expression
8
clear cell
8
cell renal
8
renal cell
8
cell carcinoma
8
learning model
4
model preoperative
4

Similar Publications

Interpretable CT Radiomics-based Machine Learning Model for Preoperative Prediction of Ki-67 Expression in Clear Cell Renal Cell Carcinoma.

Acad Radiol

January 2025

Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China (Y.X., B.X., Z.W., C.P., M.X.). Electronic address:

Rationale And Objectives: To develop and externally validate interpretable CT radiomics-based machine learning (ML) models for preoperative Ki-67 expression prediction in clear cell renal cell carcinoma (ccRCC).

Methods: 506 patients were retrospectively enrolled from three independent institutes and divided into the training (n=357) and external test (n=149) sets. Ki67 expression was determined by immunohistochemistry (IHC) and categorized into low (<15%) and high (≥15%) expression groups.

View Article and Find Full Text PDF

Introduction: Stroke patients are at high risk of developing cerebral edema, which can have severe consequences. However, there are currently few effective tools for early identification or prediction of this risk. As machine learning (ML) is increasingly used in clinical practice, its effectiveness in predicting cerebral edema risk in stroke patients has been explored.

View Article and Find Full Text PDF

Purpose: The prevalence of type 2 diabetes mellitus (T2DM) has been steadily increasing over the years. We aim to predict the occurrence of T2DM using mammography images within 5 years using two different methods and compare their performance.

Approach: We examined 312 samples, including 110 positive cases (developed T2DM after 5 years) and 202 negative cases (did not develop T2DM) using two different methods.

View Article and Find Full Text PDF

Automated classification of pathological differentiation in head and neck squamous cell carcinoma using combined radiomics models from CET1WI and T2WI.

Clin Oral Investig

December 2024

Institute of Stomatology & Research Center of Dental and Craniofacial Implants, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, China.

Article Synopsis
  • The study develops a radiomics-based model using MRI data to grade the pathological differentiation of head and neck squamous cell carcinoma (HNSCC) patients.
  • It analyzes data from 256 patients, employing an XGBoost classifier to predict outcomes based on various MRI sequences, particularly contrast-enhanced T1-weighted and T2-weighted images.
  • The findings indicate that combining these MRI sequences improves model performance, with high accuracy in predicting cancer differentiation, showcasing a promising non-invasive method for preoperative diagnosis.
View Article and Find Full Text PDF

Introduction: Since the response of patients with rectal cancer (RC) to neoadjuvant therapy is highly variable, there is an urgent need to develop accurate methods to predict the post-treatment T (pT) stage. The purpose of this study was to evaluate the utility of multi-parametric MRI radiomics models and identify the most accurate machine learning (ML) algorithms for predicting pT stage of RC.

Method: This retrospective study analyzed pretreatment clinical features of 171 RC patients who underwent 3 T MRI prior to neoadjuvant therapy and subsequent total mesorectal excision.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!